skip to content

G20 Summit: PM Modi To Visit Indonesia From November 14-16

Date:

New Delhi: Prime Minister Narendra Modi will visit the Indonesian city of Bali from November 14 to 16 to attend the G20 summit, the Ministry of External Affairs announced on Thursday.

India will assume the Presidency of the powerful grouping from the current chair Indonesia on December 1.

The G20 or Group of 20 is an intergovernmental forum of the world’s major developed and developing economies.

It comprises Argentina, Australia, Brazil, Canada, China, France, Germany, India, Indonesia, Italy, Japan, the Republic of Korea, Mexico, Russia, Saudi Arabia, South Africa, Turkey, the UK, the US and the European Union (EU).

The G20 summit will take place on November 15 and 16 in Bali and Modi is set to be among the top leaders attending it.

The G20 is the premier forum for international economic cooperation representing around 85 per cent of the global GDP, over 75 per cent of the global trade, and about two-thirds of the world population.

(With Agency Inputs) 

Click here for Latest News updates and viral videos on our AI-powered smart news

For viral videos and Latest trends subscribe to NewsMobile YouTube Channel and Follow us on Instagram

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Share post:

Subscribe

Popular

More like this
Related

IPL 2024: SRH Qualifies For Playoffs As Match Against Gujarat Abandoned Due To Rain

Sunrisers Hyderabad have officially became the third team to qualify for playoffs

Three Year Old Dead After Parent’s Forget Her In Car, Attend Wedding

As per the police, the incident occurred on Wednesday evening and the girl has been identified as Gorvika Nagar

IPL 2024: Toss Delayed In Sunrisers Hyderabad-Gujarat Titans Clash Due To Rain

It will be a crucial match for the Hyderabad-based franchise since they have to win the match to qualify for the playoffs of the IPL 2024

Another Rare Blood Disorder Linked To AstraZeneca Covid Vaccine Found

Researchers have found that the AstraZeneca vaccine sold in India under the brand name Covishield is linked to a rare blood clotting disorder known as Vaccine-Induced Immune Thrombocytopenia and Thrombosis (VITT)